Award recordCONTRACT

CSL BEHRING L.L.C.

PIID 36C24819N1050· VHA· 248-NETWORK CONTRACT OFFICE 8 (36C248)· 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY· FY2019· $78,932 net obligations· UEI H3WKVE9VBLY3· PA

Description

GLOBULIN, IMMUNE (IV) / PRIVIGEN (IV) IMMUNOGLOBULINS

First action · last action
2019-09-04 · 2019-09-04
Transactions
1
First transaction's obligation
$78,932
Base + all options value (sum of deltas)
$78,932
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D50358
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$78,932$0Base award · 2019-09-04 · this action $78,932 · running total $78,932
  • Base2019-09-04+$78,932= $78,932
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-09-04+$78,932$78,932GLOBULIN, IMMUNE (IV) / PRIVIGEN (IV) IMMUNOGLOBULINS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H3WKVE9VBLY3)

AwardOffice · PSC / listingNet obligationsFY
36C24826F0207248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$183,903FY2026
36C24826F0187248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$36,781FY2026
36C25226F0318252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$85,484FY2026
36C24826F0091248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$147,122FY2026
36C24826F0037248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$124,240FY2026
36C24824F0327248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$391,583FY2024

Other recipients under 3650 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24823N0035CARDINAL HEALTH 414, LLC248-NETWORK CONTRACT OFFICE 8 (36C248)$105,612FY2023
VA24817C0163MEDI-PHYSICS, INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$134,724FY2017
VA24817F2026ASTELLAS PHARMA US, INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$243,162FY2017
VA24816F0274BAYER HEALTHCARE PHARMACEUTICALS INC248-NETWORK CONTRACT OFFICE 8 (36C248)$11,227FY2016
VA24816P0508PETNET SOLUTIONS, INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$272,323FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24819N1050_3600_V797D50358_3600 · retrieved 2026-09-26.